Latest News
19-Apr-2024 Middle East Crisis Escalation May Hurt Pharma Exports
17-Apr-2024 Max Health Readies ₹5,500-cr Outlay for Capacity Expansion
17-Apr-2024 Meril Life Product Fails to Get Further Exemption from Price Control
15-Apr-2024 Pharma Exports to US Surge 15%
12-Apr-2024 IPC Issues Alert on Painkiller Drug Nimesulide over Adverse Reaction
  more...
Latest Reports
Apr-24 Q4FY24 Preview - Phillip Capital  
Mar-24 Domestic formulations sector secular growth stories - HDFC Securities  
Mar-24 Erosion remains benign - Nuvama  
Jan-24 Strong EBITDA growth aided by US markets - Prabhudas Lilladher  
Oct-23 Decoding The Fluorine Chemistry - Emkay Research  
  more...

Quarterly Summary December-2023
Desc Current Previous Per.Chg
Sales 58955.5 54426.0 8.3
Otherincome 2097.6 1498.2 40.0
Expense 47315.8 44570.7 6.2
RawMaterial 18479.5 17844.3 3.6
StaffCost 9092.4 8155.9 11.5
ExciseDuty 69.8 48.3 44.6
OtherExp 14380.6 13485.6 6.6
Interest 1113.5 948.4 17.4
GrossProfit 13813.5 11092.8 24.5
Depreciation 2721.7 2595.5 4.9
Tax 2307.6 2171.4 6.3
NetProfit 8879.1 6488.7 36.8
Total.Comp 178 -- --
Source: ETIG Database

Sectoral Companies As on 18 Apr 2024
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 364009.80
Cipla 108802.52
Dr.Reddy's 99409.71
Divi's Lab 98677.06
Mankind Phar 96039.84
Zydus Life 94210.51
Torrent Phar 86217.59
Lupin 72622.63
Aurobindo Ph 65321.99
Alkem Labora 55575.81
Abbott (I) 55368.26
IPCA Lab. 34312.93
GlaxoSmith.P 32004.94
  click here for the complete list